poisar

Stocks · News reference

JP Morgan Initiates Coverage On Kestra Medical Techs with Overweight Rating, Announces Price Target of $30

Aug 10, 2026, 10:10 AMBenzinga Newsdesk

JP Morgan analyst Robbie Marcus initiates coverage on Kestra Medical Techs (NASDAQ:KMTS) with a Overweight rating and announces Price Target of $30.

Read original sourceMore stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

KMTS
Source
benzinga
Observed
Aug 10, 2026, 10:10 AM
Checked
Aug 10, 2026, 10:10 AM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Aug 26, 2026, 10:00 AMNa

    Kestra Appoints Curtis Kopf as Senior Vice President of Customer Experience

    Kestra Medical Technologies announced the appointment of Curtis Kopf as Senior Vice President of Customer Experience in a newly created role. Kopf, who previously led global customer experience at Insulet Corporation and served as Chief Experience Officer at REI, will oversee the patient experience for the ASSURE WCD device. The appointment aligns with Kestra's investments in commercial capabilities and artificial intelligence initiatives to drive growth and improve patient support throughout their cardiac recovery journey.

    Read original at globenewswire-inc
    KMTS